Target Price | $21.60 |
Price | $6.24 |
Potential |
246.15%
register free of charge
|
Number of Estimates | 10 |
10 Analysts have issued a price target Relay Therapeutics Inc 2025 .
The average Relay Therapeutics Inc target price is $21.60.
This is
246.15%
register free of charge
$29.00
364.74%
register free of charge
$14.00
124.36%
register free of charge
|
|
A rating was issued by 11 analysts: 11 Analysts recommend Relay Therapeutics Inc to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Relay Therapeutics Inc stock has an average upside potential 2025 of
246.15%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 25.55 | 10.18 |
1,751.45% | 60.17% | |
EBITDA Margin | -1,464.38% | -3,974.06% |
93.41% | 171.38% | |
Net Margin | -1,455.82% | -3,852.09% |
94.18% | 164.60% |
11 Analysts have issued a sales forecast Relay Therapeutics Inc 2024 . The average Relay Therapeutics Inc sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an Relay Therapeutics Inc EBITDA forecast 2024. The average Relay Therapeutics Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
4 Relay Therapeutics Inc Analysts have issued a net profit forecast 2024. The average Relay Therapeutics Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -2.79 | -2.94 |
7.72% | 5.38% | |
P/E | negative | |
EV/Sales | 19.47 |
4 Analysts have issued a Relay Therapeutics Inc forecast for earnings per share. The average Relay Therapeutics Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Relay Therapeutics Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Relay Therapeutics Inc...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.